Rupee Slide to 95: Bullish for Pharma, IT, Auto Ancillaries; Power

Financial expert Amisha Vora suggests that a significant depreciation of the Indian Rupee to 94-95 against the US Dollar would create a 'goldmine' for specific sectors. These include export-oriented industries such as pharmaceuticals, IT services, and auto ancillaries, with metals also benefiting. Additionally, a long-term growth trend is identified in energy and power infrastructure, fueled by the expansion of data centers.

A weaker Rupee directly enhances the competitiveness of Indian exports by making them cheaper for foreign buyers and increases the Rupee-denominated earnings for companies with significant foreign revenue. This directly impacts the top and bottom lines of export-heavy sectors. The focus on power infrastructure highlights a structural growth theme driven by digital transformation.

Pharmaceutical companies (e.g., SUNPHARMA, DRREDDY), IT services giants (e.g., TCS, INFOSYS, WIPRO), and auto ancillary firms (e.g., BOSCHLTD, MINDAIND) are expected to see positive impacts due to improved export realizations. Metal stocks (e.g., TATASTEEL, HINDALCO) could also benefit. Power infrastructure companies (e.g., POWERGRID, NTPC, SIEMENS) are poised for long-term growth, making them attractive for accumulation on dips.

Traders should closely monitor the INR/USD exchange rate for signs of further depreciation towards the 94-95 range. Also, track global demand for Indian exports and government policies supporting these sectors. For power infrastructure, watch for new data center project announcements and government initiatives in renewable energy and grid modernization.

• •Rupee slide to 94-95 is a 'goldmine' for certain sectors.
• •Export-oriented sectors like pharma, IT, and auto ancillaries will benefit.
• •Metals also stand to benefit quietly.
• •Long-term growth in energy and power infrastructure, driven by data centers.
• •Investors should accumulate power infrastructure stocks on dips.